Abatacept in Double Cord Blood Unit Transplant
ABBA CORD: Double Umbilical Cord Blood Transplants With Abatacept for Graft Versus Host Disease Prophylaxis
More Information
- Trial Status
- Not yet accepting
- Trial Phase
- Phase 2
- Enrollment
- 20 patients (estimated)
- Sponsors
- Case Comprehensive Cancer Center
- Tags
- Immunomodulatory Drug (IMiD), T Cell
- Trial Type
- Supportive
- Last Update
- 1 week ago
- SparkCures ID
- 2019
- NCT Identifier
- NCT06680661
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.